×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media

October 13, 2022
  • Enables GE Healthcare to secure increasing supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) imaging procedures
  • Supports GE Healthcare’s broader commitment to address future demand for iodinated contrast media and deliver 30 million more patient doses annually by 2025
  • Investment plan also includes opening this week a new manufacturing line at its Cork, Ireland, contrast media production facility

Chalfont St Giles, UK – 13 October 2022: GE Healthcare’s Pharmaceutical Diagnostics business has ann

business unit
Press Release

GE Announces Filing of Form 10 Registration Statement for Planned Spin-Off of GE HealthCare

October 11, 2022

Key milestone in GE HealthCare’s journey to becoming standalone public company leading precision health innovation; marks continued progress on GE’s plans to form three companies 

business unit
tags
Press Release

GE Healthcare: Riparte da roma il tour del “women health truck” per la salute della donna

October 06, 2022

Visitando il sistema mobile, gli operatori sanitari potranno scoprire le tecnologie di imaging medicale più all’avanguardia e le potenzialità dell'intelligenza artificiale nella diagnostica per immagini, per una sempre migliore esperienza della paziente.
In arrivo a Roma nel mese dedicato alla prevenzione del tumore al seno, il truck è partito nell’ottobre 2021 e ha già attraversato sette Paesi in tutta Europa. Prossime tappe Spagna e Germania
 

business unit
Press Release

GE Healthcare’s AIR Recon DL Receives FDA Clearance of 3D and Motion-Insensitive Imaging Applications for Next-Level Image Quality and Patient Experience in MRI

September 29, 2022
  • Extending deep learning-based AIR Recon DL compatibility to 3D & PROPELLER has the potential to enable more confident patient diagnoses in MRI

Chicago, US, September 29, 2022 – GE Healthcare announced US FDA 510(k) clearance of its breakthrough AIR Recon DL for 3D and PROPELLER imaging sequences[1].

business unit
Press Release

GE Healthcare showcases innovations designed to build cardiology care of the future at TCT2022

September 16, 2022

BOSTON - September 16, 2022: Cardiovascular disease (CVD) continues to grow, with CVDs being the leading cause of death globally[1]. Nearly 18 million people died from CVDs in 2019, representing 32 percent of all global deaths and of these deaths, 85 percent were due to heart attack and stroke.[2] As a result, cardiology procedures are shifting rapidly – requiring a multi-disciplinary approach to optimize workflow, deliver better outcomes and offer patients the best treatment options.  

business unit
tags
Press Release

GE Healthcare and Wayra collaborate with seven healthtech start-ups to drive the digital transformation of healthcare across Europe, the Middle East and Africa

September 14, 2022

Chalfont St Giles, United Kingdom; September 13th – Seven healthtech start-ups have officially been named as the second cohort of the Edison Accelerator in EMEA Europe, the Middle East and Africa.  Edison Accelerator is a healthcare start-up and scale-up acceleration & healthcare provider collaboration program designed by GE Healthcare, in partnership with the innovation organization, Wayra UK

business unit
Press Release

GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

September 13, 2022
  • Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD)
  • Trial also met its first key secondary endpoint, demonstrating higher diagnostic efficacy for [18F]flurpiridaz PET compared to SPECT Myocardial Perfusion Imaging (MPI)
  • With a half-life roughly 12 times longer than currently approved cardiac PET radiotracers, if approved, [18F]flurpiridaz has the potential to expand patient access to PET MPI
  • This radiotracer is part of GE He
    business unit
    tags
Press Release

GE Announces Board of Directors for Future Independent GE HealthCare; Confirms Target Spin-Off Timing of First Week of January 2023

September 12, 2022

GE HealthCare on track toward future as a standalone public company leading precision health innovation
 
•    Board members bring strong mix of expertise, industry experience and diverse perspectives to help GE HealthCare lead a new era of more precise, connected, and compassionate care
•    Tax free spin-off expected to be completed first week of January 2023
•    GE HealthCare to host investor day on December 8, 2022, in New York, NY

business unit
tags
Press Release

Wipro GE Healthcare launches its first ‘Made in India – AI enabled Cath lab’ to address cardiovascular disease burden in India

September 05, 2022
  • The Intelligent AI - AutoRight technology powered by Edison, enables precision healthcare delivery
  • To enable minimally invasive procedures with the objective of risk minimization

Bengaluru, September 05, 2022 – GE Healthcare, a leading global medical technology, diagnostics and digital solutions innovator today announced the launch of its first ‘Made in India’, ‘AI-powered’ Cath lab - Optima IGS 320 to advance cardiac care in India.

business unit
Press Release

Wipro GE Healthcare Collaborates with Boston Scientific to Advance Cardiac Care in India

August 16, 2022
  • To provide a full spectrum of innovative solutions, the partnership aims to empower better heart care and build efficiency across the care pathway journey of the patient
  • Unlocking the potential of interventional cardiology will be a step forward in delivering precision health

Bengaluru, August 16, 2022, – GE Healthcare, a leading global medical technology, diagnostics and digital solutions innovator, today announced its collaboration with

For media inquiries, please contact:

Shipra Singh
GE
+91 9769496988
[email protected]
Tasneem Savliwala
+91 8850291322
[email protected]
business unit
Subscribe to GE Healthcare